forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Receptor Agonist Market Analysis forecast glp-1 prescriptions growth 2025

As a result of the different event rates in the two studies, the median durations of follow-up were also substantially different (3.8 years in LEADER vs

concluded that tirzepatide was found to be effective in improving cardiac dysfunction and increasing survival rates in mice that were treated with LPS

5 Metabolic liver disease In a 240-week phase 3 clinical trial of 1,200 adults with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis stages F2-F3 (mean BMI 34.6), semaglutide 2.4 mg weekly improved liver histology (Non-alcoholic Fatty Liver Disease Activity Score, inflammation, and ballooning and steatosis) in the first 800 participants over 72 weeks

The concern stems from animal reproduction studies where these drugs affected normal fetal development pathways, though human pregnancy data remains limited because ethical guidelines prevent controlled trials in pregnant women

Huang, J